Previous close | 13.50 |
Open | 13.10 |
Bid | 14.30 |
Ask | 14.80 |
Strike | 240.00 |
Expiry date | 2024-12-20 |
Day's range | 13.10 - 14.50 |
Contract range | N/A |
Volume | |
Open interest | 92 |
Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER.
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.